Found: 33
Select item for more details and to access through your institution.
Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 11, p. 1821, doi. 10.1007/s00432-012-1259-2
- By:
- Publication type:
- Article
The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential tumour gene.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 877, doi. 10.1111/bjh.16595
- By:
- Publication type:
- Article
Cereblon expression in multiple myeloma: not ready for prime time - Response to Lodé et al.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 2, p. 285, doi. 10.1111/bjh.12477
- By:
- Publication type:
- Article
High expression of cereblon ( CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 695, doi. 10.1111/bjh.12338
- By:
- Publication type:
- Article
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.
- Published in:
- Journal of Clinical Apheresis, 2017, v. 32, n. 4, p. 224, doi. 10.1002/jca.21496
- By:
- Publication type:
- Article
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant‐ineligible patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 1008, doi. 10.1002/ajh.27280
- By:
- Publication type:
- Article
Impfempfehlungen beim Multiplen Myelom: ein Konsensbericht des European Myeloma Network.
- Published in:
- Kompass Onkologie, 2022, v. 9, n. 1, p. 3, doi. 10.1159/000522451
- By:
- Publication type:
- Article
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 9, p. 1083, doi. 10.1007/s00277-011-1192-5
- By:
- Publication type:
- Article
Successful treatment of a patient with lymphocyte-predominant Hodgkin’s lymphoma with yttrium-90-ibritumomab tiuxetan.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 4, p. 322, doi. 10.1111/j.1600-0609.2008.01107.x
- By:
- Publication type:
- Article
Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2801, doi. 10.1002/cncr.22318
- By:
- Publication type:
- Article
âLaying on of handsâ improves well-being in patients with advanced cancer.
- Published in:
- Supportive Care in Cancer, 2007, v. 15, n. 2, p. 143, doi. 10.1007/s00520-006-0147-1
- By:
- Publication type:
- Article
P-096: Tackling pyrimidine biosynthesis - CTP Synthase 1 is a novel target in the treatment of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S91, doi. 10.1016/S2152-2650(21)02230-8
- By:
- Publication type:
- Article
P-061: Single-cell whole-exome DNA sequencing traces clonal trajectory in paired evolution of MGUS to multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S72, doi. 10.1016/S2152-2650(21)02195-9
- By:
- Publication type:
- Article
The first-in-class BMI-1 modulators PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e113, doi. 10.1016/j.clml.2019.09.188
- By:
- Publication type:
- Article
Defining Clonal Plasticity Using Whole Exome Sequencing in Single Cells in an Index Case of amp1q21 Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e108, doi. 10.1016/j.clml.2017.03.196
- By:
- Publication type:
- Article
High IKAROS Expression in Bone Marrow Environmental, But Not in Myeloma Cells Predicts for Survival with Lenalidomide-Dexamethasone Therapy in Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e91, doi. 10.1016/j.clml.2017.03.162
- By:
- Publication type:
- Article
Ixazomib in Combination With Thalidomide and Dexamethasone as Treatment for Patients With Relapsed/Refractory Multiple Myeloma: An Ongoing Phase II Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e75, doi. 10.1016/j.clml.2017.03.136
- By:
- Publication type:
- Article
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program
- Published in:
- Transfusion, 2011, v. 51, n. 5, p. 968, doi. 10.1111/j.1537-2995.2010.02896.x
- By:
- Publication type:
- Article
IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 269, doi. 10.1002/ajh.24634
- By:
- Publication type:
- Article
Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 295, doi. 10.1002/ajh.24268
- By:
- Publication type:
- Article
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0247-4
- By:
- Publication type:
- Article
Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-014-0105-1
- By:
- Publication type:
- Article
Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 3, p. 325, doi. 10.1111/j.1365-2141.2011.08689.x
- By:
- Publication type:
- Article
Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19<sup>+</sup> cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 4, p. 852, doi. 10.1046/j.1365-2141.2002.03529.x
- By:
- Publication type:
- Article
Seltene Differenzialdiagnose bei bilateraler Gonalgie.
- Published in:
- Der Pathologe, 2022, v. 43, n. 6, p. 449, doi. 10.1007/s00292-022-01095-z
- By:
- Publication type:
- Article
Additional Lesions Detected in Therapeutic Scans with Lu-DOTATATE Reflect Higher Affinity of <sup>177</sup>Lu-DOTATATE for Somatostatin Receptors.
- Published in:
- Oncology, 2011, v. 80, n. 5/6, p. 326, doi. 10.1159/000329808
- By:
- Publication type:
- Article
The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 333, doi. 10.1634/theoncologist.2015-0303
- By:
- Publication type:
- Article
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross‐sectional analysis of the randomized AGMT 02 study.
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 494, doi. 10.1002/jha2.925
- By:
- Publication type:
- Article
Reduced alpha diversity of the oral microbiome correlates with short progression‐free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib‐based therapy (AGMT MM 1, phase II trial).
- Published in:
- EJHaem, 2021, v. 2, n. 1, p. 102, doi. 10.1002/jha2.130
- By:
- Publication type:
- Article
Absence of p53 deletions in bone marrow plasma cells of patients with monoclonal gammopathy of undedetermined significance.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 4, p. 1161, doi. 10.1046/j.1365-2141.1998.01124.x
- By:
- Publication type:
- Article